通过FKBP52激活NFAT,通过抑制p53促进癌细胞增殖
Shunsuke Hanaki1, Makoto Habara1, Haruki Tomiyasu1
1Department of Veterinary Biochemistry, Yamaguchi University, Yamaguchi, Japan.
Life science alliance
|May 28, 2024
概括
FK506结合蛋白52 (FKBP52) 通过NFAT通路调节MDM2转录,促进癌细胞的增殖. 抑制FKBP52可以稳定p53,抑制瘤生长.
科学领域:
- 分子生物学分子生物学
- 癌症研究 癌症研究
- 细胞生物学 细胞生物学
背景情况:
- FKBP52在癌症中被上调,并调节类固醇激素受体.
- FKBP52的枯竭抑制了细胞的增殖,但机制尚不清楚.
研究的目的:
- 阐明FKBP52调节细胞增殖的机制.
- 为了确定参与FKBP52介导细胞生长的分子参与者.
主要方法:
- 研究了FKBP52枯竭对MDM2转录和p53稳定性的影响.
- 确定NFATc1和NFATc3作为MDM2.2的调节者.
- 研究了FKBP52和NFATc3.3之间的相互作用.
- 评估了氨酸和细胞内在MDM2调节中的作用.
主要成果:
- 耗尽FKBP52降低了MDM2转录,稳定了p53,并抑制了细胞增殖.
- 确定NFATc1和NFATc3是调节MDM2.2的转录因子.
- FKBP52促进了NFATc3的核转移.
- 氨酸和细胞内影响了MDM2的转录.
结论:
- FKBP52通过NFAT-MDM2-p53轴促进细胞增殖.
- 抑制FKBP52代表了激活p53和减少癌细胞增殖的潜在治疗策略.
相关概念视频
Abnormal Proliferation
4.5K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.5K
Interactions Between Signaling Pathways
6.3K
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.3K
NF-κB-dependent Signaling Pathway
7.4K
The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
NF-κB-dependent Signaling Mechanism
The...
7.4K
mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K
The Intrinsic Apoptotic Pathway
6.5K
Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
6.5K
Negative Regulator Molecules
35.3K
Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
35.3K


